Late onset periprosthetic joint infection of the knee caused by Streptococcus anginosus. Case presentation and literature review.

Periprosthetic joint infection (PJI) is one of the most dramatic complications of joint arthroplasty. Although streptococcal bone and joint infections are less common than staphylococcal cases, their role as causative agents of bone and joint remains significant accounting for at least 10% of PJIs. Streptococcus anginosus group (SAG) bacteria are usually found in the normal flora of the urogenital tract, intestinal tract and oropharynx and could cause pyogenic infections to affect brain, lungs and liver. SAG bacteria are uncommonly reported as a cause of osteomyelitis and the involvement of a joint represent a rare event. S. anginosus has been anecdotical related to implant devices infections such as vascular prosthesis or orthopedic implants, however, PJI of the knee has never been fully reported before. We describe the case of a late onset periprosthetic knee infection due to Streptococcus anginosus successfully treated by a two-stage revision arthroplasty and postoperative parenteral Vancomycin, (2 g per day) and Levofloxacin (750 mg per day) for 4 weeks and then oral Levofloxacin for a further 2 weeks.

[1]  C. Perka,et al.  Long-term antimicrobial suppression prevents treatment failure of streptococcal periprosthetic joint infection. , 2019, The Journal of infection.

[2]  J. Argenson,et al.  Outcome of single-stage versus two-stage exchange for revision knee arthroplasty for chronic periprosthetic infection , 2019, EFORT open reviews.

[3]  O. Borens,et al.  Periprosthetic joint infection: current concepts and outlook , 2019, EFORT open reviews.

[4]  A. Capone,et al.  Long-term results of isolated acetabular revisions with reinforcement rings: a 10- to 15-year follow-up , 2018, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[5]  S. Zanetti,et al.  In vitro activity of essential oils against Pseudomonas aeruginosa isolated from infected hip implants. , 2018, Journal of infection in developing countries.

[6]  J. Parvizi,et al.  Determining the Role and Duration of the "Antibiotic Holiday" Period in Periprosthetic Joint Infection. , 2018, The Journal of arthroplasty.

[7]  Mihoko Furuichi,et al.  Sites of infection associated with Streptococcus anginosus group among children. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[8]  T. Peel,et al.  Prosthetic Joint Infections , 2018, Springer International Publishing.

[9]  Y. Geffen,et al.  The pyogenic potential of the different Streptococcus anginosus group bacterial species: retrospective cohort study , 2017, Epidemiology and Infection.

[10]  M. Ferrari,et al.  The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  G. Meloni,et al.  Total hip prosthesis complication, periprosthetic infection with external fistulizing due to Enterobacter cloacae complex multiple drugs resistance: A clinical case report , 2017, International journal of surgery case reports.

[12]  C. Perka,et al.  High failure rates in treatment of streptococcal periprosthetic joint infection: RESULTS FROM A SEVEN‐YEAR RETROSPECTIVE COHORT STUDY , 2017, The bone & joint journal.

[13]  A. Capone,et al.  Periprosthetic fractures: epidemiology and current treatment , 2017 .

[14]  A. Reyes Valdivia,et al.  Late aortic silver graft re-infection due to Streptococcus milleri group (Streptococcus anginosus). Case report and literature review. , 2017, Revista Espanola de Quimioterapia.

[15]  Hiroyuki Suzuki,et al.  Bloodstream infections caused by Streptococcus anginosus group bacteria: A retrospective analysis of 78 cases at a Japanese tertiary hospital. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[16]  A. Stein,et al.  Clinical features and outcome of bone and joint infections with streptococcal involvement: 5-year experience of interregional reference centres in the south of France , 2016, New microbes and new infections.

[17]  H. Mukae,et al.  The clinical features of respiratory infections caused by the Streptococcus anginosus group , 2015, BMC Pulmonary Medicine.

[18]  G. Marongiu,et al.  The loss of extension test (LOE test): a new clinical sign for the anterior cruciate ligament insufficient knee , 2013, Journal of Orthopaedics and Traumatology.

[19]  A. Hanssen,et al.  Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  E. Sariali,et al.  Infected total hip arthroplasty revision: one- or two-stage procedure? , 2012, Orthopaedics & traumatology, surgery & research : OTSR.

[21]  P. Noble,et al.  The New Knee Society Knee Scoring System , 2012, Clinical orthopaedics and related research.

[22]  F. Ennas,et al.  Periprosthetic femoral fractures: risk factors and current options to treatment. , 2011, Aging clinical and experimental research.

[23]  P. Bejon,et al.  Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology , 2010, The Journal of antimicrobial chemotherapy.

[24]  R. Bonomo,et al.  Streptococcus anginosus (Streptococcus milleri Group) Pyomyositis in a 50-Year-Old Man with Acquired Immunodeficiency Syndrome: Case Report and Review of Literature , 2010, Infection.

[25]  F. Dronda,et al.  [Osteomyelitis around a knee prosthesis due to Streptococcus anginosus]. , 1992, Revista clínica española (Ed. impresa).